Key result
Percutaneous coronary intervention reduced the incidence of in-hospital death compared to medical therapy in elderly patients with acute myocardial infarction and renal dysfunction.
Why the study?
Does percutaneous coronary intervention reduce in-hospital death and MACE in elderly patients (>75 years) with acute myocardial infarction and renal dysfunction compared to medical therapy?
Cohort (n=1,458)
Yes
Does percutaneous coronary intervention reduce in-hospital death and MACE in elderly patients (>75 years) with acute myocardial infarction and renal dysfunction compared to medical therapy?
Answers are grounded in this paper and cite their sources.
In elderly patients with acute myocardial infarction and renal dysfunction, percutaneous coronary intervention is associated with significantly lower in-hospital mortality and improved long-term MACE-free survival compared to medical therapy alone.
This study aimed to evaluate the effects of percutaneous coronary intervention (PCI) on short- and long-term major adverse cardiac events (MACE) in elderly (>75 yr old) acute myocardial infarction (AMI) patients with renal dysfunction. As part of Korea AMI Registry (KAMIR), elderly patients with AMI and renal dysfunction (GFR<60 mL/min) received either medical (n=439) or PCI (n=1,019) therapy. Primary end point was in-hospital death. Secondary end point was MACE during a 1 month and 1 yr follow-up. PCI group showed a significantly lower incidence of in-hospital death (20.0% vs 14.3%, P=0.006). Short-term and long-term MACE rates were higher in medical therapy group (31.9% vs 19.0%; 57.7% vs 31.3%, P<0.001), and this difference was mainly attributed to cardiac death (29.3% vs 17.6%; 51.9% vs 25.0%, P<0.001). MACE-free survival time after adjustment was also higher in PCI group on short-term (hazard ratio, 0.67; confidence interval, 0.45-0.98; P=0.037) and long-term follow-up (hazard ratio, 0.61, confidence interval, 0.45-0.83; P=0.002). In elderly AMI patients with renal dysfunction, PCI therapy yields favorable in-hospital and short-term and long-term MACE-free survival.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2013) conducted a cohort in Acute Myocardial Infarction with Renal Dysfunction (n=1,458). Percutaneous coronary intervention (PCI) vs. Medical therapy was evaluated on In-hospital death (p=0.006). Percutaneous coronary intervention reduced the incidence of in-hospital death compared to medical therapy in elderly patients with acute myocardial infarction and renal dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: